Elsevier

Journal of Ethnopharmacology

Volume 127, Issue 2, 3 February 2010, Pages 205-209
Journal of Ethnopharmacology

Is Chios mastic gum effective in the treatment of functional dyspepsia? A prospective randomised double-blind placebo controlled trial

https://doi.org/10.1016/j.jep.2009.11.021Get rights and content

Abstract

Background

Herbal remedies are increasingly popular for the treatment of functional dyspepsia. Chios mastic gum is a resinous exudate from the stem of Pistacia lentiscus var. chia. It is a traditional natural remedy used throughout the eastern Mediterranean.

The aim of this study was to assess the efficacy of Chios mastic gum in patients with functional dyspepsia.

Methods

One hundred and forty eight patients fulfilling Rome II criteria for functional dyspepsia were randomly assigned to receive either Chios mastic gum 350Ā mg three times daily or placebo. After 3 weeks of treatment the change from baseline in the severity of symptoms of functional dyspepsia was assessed using the Hong Kong index of dyspepsia. Patientsā€™ global assessment of efficacy was also evaluated.

Results

The symptom score after treatment was significantly lower in the Chios mastic gum than in the placebo group ((14.78Ā Ā±Ā 1.78) vs (19.96Ā Ā±Ā 1.83)) (pĀ <Ā 0.05). There was a marked improvement of symptoms in 40% of patients receiving placebo and in 77% of patients receiving Chios mastic gum (pĀ <Ā 0.02). Individual symptoms that showed significant improvement with Chios mastic gum were: stomach pain in general, stomach pain when anxious, dull ache in the upper abdomen and heartburn (<0.05 for all four symptoms).

Conclusion

Chios mastic gum significantly improves symptoms in patients with functional dyspepsia compared to placebo.

Introduction

Dyspepsia is a very common problem that affects large numbers of individuals worldwide especially in the Westernised world. Patients with dyspepsia problems are treated both by primary care physicians as well as gastroenterologists in the different health care systems. Dyspepsia in the absence of an identifiable structural lesion in the upper gastrointestinal system is referred to as functional dyspepsia (Talley et al., 1999).

Treatment of functional dyspepsia remains problematic. Historically the H2-receptor antagonists have been tried in dyspepsia but the results were generally disappointing (Talley et al., 1986, Kato et al., 2005, Ashizawa et al., 2006,). At about the same time prokinetics were also used in functional dyspepsia. Mosapride showed a small improvement in symptoms in a small trial (Wu et al., 2006). Cisapride, a related compound has shown superiority over placebo in meta-analyses but its use is now severely restricted due to cardiac side effects (Veldhuyzen van Zanten et al., 2001). Itopride a newer D2-receptor antagonist has shown some promising results in one large and two smaller trials (Amarapurkar and Rane, 2004, Zhu et al., 2005, Holtmann et al., 2006) but it has failed Phase III trials (Talley et al., 2008). As for proton pump inhibitors recent meta-analyses have shown efficacy but the effect was modest (Moayyedi et al., 2004, Van Zanten et al., 2006). Helicobacter pylori eradication has shown some minor benefit in recent trial and meta-analyses (Moayyedi et al., 2003, Di Mario et al., 2005, Ang et al., 2006). As for alosetron, whose use is restricted in some countries due to side effects it has shown benefit in functional dyspepsia (Talley et al., 2001).

As treatment of functional dyspepsia with conventional medication remains unsatisfactory, herbal remedies such as iberogast (Melzer et al., 2004a, Melzer et al., 2004b, Von Arnim et al., 2007), and artichoke leaf extract (Holtmann et al., 2003, Meier and Brignoli, 2005) have been tried in small studies for the treatment of this condition. The results have been promising and results from bigger trials are awaited.

Chios mastic gum is a resinous exudate which is derived from the stem of the bush Pistacia lentiscus var. chia. Chios mastic gum is usually sold as a chewing gum. It is also used in cooking and cosmetics. There have been references to Chios mastic gum as a medicinal product for gastrointestinal upsets since ancient times (Kaliora et al., 2007). It is still widely used as a remedy for these in many parts of the Mediterranean basin and the Middle East (Triantafyllou et al., 2007).

Although Chios mastic gum is traditionally used in dyspepsia like symptoms no properly designed trial has ever been conducted to test its efficacy. Our aim was to evaluate the efficacy on Chios mastic gum in patients with functional dyspepsia in terms of improvement of the perception of symptoms.

Section snippets

Materials and methods

The trial was a 3-week double-blind randomised placebo controlled study designed to investigate the effects of Chios mastic gum on functional dyspepsia symptoms.

The study was conducted in Chios District General Hospital Skylitsion, Chios, Greece.

The study was approved by the local ethics committee (Reference no. MGCGH0031/05) and the Greek Medicines Agency (Reference no CGH266/05 B). All procedures followed were in accordance with the Declaration of Helsinki (1975, amended 2000) on

Results

Two hundred and forty one patients were assessed for eligibility. Eighty-three patients were excluded for various reasons. One hundred and forty eight patients were enrolled and randomised. Seventy-four received Chios mastic gum and seventy-four received placebo. One patient in the active treatment was lost to follow up. Four patients (one in the active treatment group and three in the placebo group) discontinued treatment because of lack of efficacy. The first patient entered the study in

Discussion

Due to the paucity of effective conventional medication for the treatment of functional disorders of the alimentary tract natural remedies and herbal preparations have been tested for these conditions during the past few years.

A few studies for the treatment of irritable bowel syndrome have confirmed some efficacy for compounds such as peppermint oil, iberogast and Chinese herbal preparations (Liu et al., 1997, Bensoussan et al., 1998, Pittler and Ernst, 1998, Madisch et al., 2004, Hussain and

Role of the funding source

This study was funded by a grant from the Mastic Gum Producers Cooperative to KJ Dabos. The study was designed by the principal investigator and the design was approved by the sponsor. The Statistics Section of the Cooperative provided statistical advice for the analysis and interpretation of the data.

Conflict of interest

KJ Dabos received travel bursaries from the sponsor. E Sfika was an employee of the sponsor during the study period. LJV, DF, GIA, GG, have nothing to declare.

Acknowledgements

The authors acknowledge all those who contributed significantly to this work. In particular Elias Smyrnioudis from the Mastic Gum Growers Cooperative for packaging and assuring blinding of the medication and Christos Kartalis for fruitful discussions about the project. The trial is registered in ISRCTN and its unique ID is ISRCTN51942129.

References (38)

  • K. Dimas et al.

    A mastic gum extract induces suppression of growth of human colorectal tumour xenografts in immunodefficient mice

    In Vivo

    (2009)
  • F. Di Mario et al.

    Natural course of functional dyspepsia after Helicobacter pylori eradication: a seven year survey

    Digestive Diseases and Science

    (2005)
  • E.M. Giner-Larza et al.

    Anti-inflammatory triterpenes from Pistacia terebinthus gals

    Planta Medica

    (2002)
  • G. Holtmann et al.

    Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six-week placebo-controlled, double-blind, multicentre trial

    Alimentary Pharmacology and Therapeutics

    (2003)
  • G. Holtmann et al.

    A placebo-controlled trial of itopride in functional dyspepsia

    New England Journal of Medicine

    (2006)
  • M. Hostettmann-Kaldas et al.

    Moronic acid, a simple triterpenoid keto acid with antimicrobial activity isolated from Ozoroa mucronata

    Planta Medica

    (1979)
  • W.C. Hu et al.

    The Hong Kong index of dyspepsia: a validated symptom severity questionnaire for patients with dyspepsia

    Journal of Gastroenterology and Hepatology

    (2002)
  • Z. Hussain et al.

    Systematic review: complementary and alternative medicine in the irritable bowel syndrome

    Alimentary Pharmacology and Therapeutics

    (2006)
  • F.U. Huwez et al.

    Mastic gum kills Helicobacter pylori

    New England Journal of Medicine

    (1998)
  • Cited by (0)

    View full text